CytomX to Present at Upcoming Healthcare Conferences

NEXT STORY
DBV Technologies Reports Full Year 2018 Financial Results and Provides Operational Update
PREV STORY
Kura Oncology Reports Fourth Quarter and Full Year 2018 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designation in combination with Tecentriq for PD-L1-high non-small cell lung cancer

author_avatar
NASDAQ Market News

Rapid Microbiology Testing Market by Product, Method and Applications – Global Forecast to 2026

author_avatar
NASDAQ Market News

$712.91Mn by 2028 Photomedicine Devices and Technologies Market Size Lead by Photodynamic Therapy (5.3% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com

author_avatar
NASDAQ Market News